Shares of Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report) passed above its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $5.78 and traded as high as $6.34. Health Sciences Acquisitions Co. 2 shares last traded at $6.01, with a volume of 452,902 shares changing hands.
Health Sciences Acquisitions Co. 2 Trading Up 4.9%
The business’s 50-day simple moving average is $5.78 and its 200-day simple moving average is $4.60.
About Health Sciences Acquisitions Co. 2
Health Sciences Acquisitions Corp. 2 was a special purpose acquisition company (SPAC) formed to pursue a merger or similar business combination, with a focus on the health sciences and healthcare sectors. It did not operate a healthcare business or offer its own products or services. In January 2023, it completed a business combination with Orchestra BioMed, a medical technology company developing therapies for cardiovascular and other conditions. The combined company became Orchestra BioMed Holdings, Inc., which trades under the symbol OBIO; HSAQ is no longer its operating ticker.
Further Reading
- Five stocks we like better than Health Sciences Acquisitions Co. 2
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Health Sciences Acquisitions Co. 2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions Co. 2 and related companies with MarketBeat.com's FREE daily email newsletter.
